At Noetik, we are pioneering advancements in precision oncology to redefine cancer care. Our goal is to build multi-omic foundational models of cancer that identify novel target biology and inform optimal patient selection. We are working to address some of the most challenging types of cancer and are continually expanding our vision into building a pan- cancer company to further our impact.
We don’t underestimate the magnitude of these ambitions, but we believe patients deserve no less than breakthrough therapies that can transform their lives.
Achieving these goals requires collaboration and shared vision. By partnering with scientific leaders, industry pioneers, and institutions, we can combine and innovate to accelerate the development of precision treatments for those who need them most. Together, we can drive meaningful change in the fight against cancer.
To discuss how you can partner with us, get in Touch
Human Platform:
Multimodal spatial data purpose-built for self supervised learning
Collaboration opportunities around NOETIK’s proprietary NSCLC and other tumor datasets
Multimodal AI: Self supervised foundation models of tumor biology
Direct collaboration to advance partner’s clinical stage programs
Mouse Platform: Scaled In Vivo validation of dozens of targets in the same mouse
Focused discovery to development collaboration leveraging NOETIK reverse translation capabilities to identify novel targets
Pipeline: Multiple patient-specific oncology programs
Seeking to in-license late pre-clinical and clinical assets